BioNTech SE (BNTX)
102.12
+2.65
(+2.66%)
USD |
NASDAQ |
Apr 16, 16:00
102.05
-0.07
(-0.07%)
After-Hours: 20:00
BioNTech Free Cash Flow : 289.80M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| GSK Plc | 5.712B |
| Merck & Co., Inc. | 12.36B |
| Novavax, Inc. | -251.02M |
| Novo Nordisk A/S | 4.403B |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 351.53M |
| Cash from Investing (Quarterly) | -3.086B |
| Cash from Financing (Quarterly) | -16.44M |
| Free Cash Flow Per Share (Quarterly) | 1.130 |
| Free Cash Flow to Equity (Quarterly) | 251.29M |
| Free Cash Flow to Firm (Quarterly) | 287.14M |
| Free Cash Flow Yield | 1.17% |